Great West Life Assurance Co. Can Trims Holdings in Natus Medical Inc (NASDAQ:BABY)

Great West Life Assurance Co. Can trimmed its holdings in Natus Medical Inc (NASDAQ:BABY) by 6.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,183 shares of the medical equipment provider’s stock after selling 3,057 shares during the period. Great West Life Assurance Co. Can owned 0.15% of Natus Medical worth $1,690,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Koch Industries Inc. lifted its holdings in Natus Medical by 7,423.5% during the 2nd quarter. Koch Industries Inc. now owns 462,472 shares of the medical equipment provider’s stock worth $450,000 after purchasing an additional 456,325 shares during the last quarter. Hillcrest Asset Management LLC bought a new position in shares of Natus Medical in the 3rd quarter valued at $8,966,000. Daruma Capital Management LLC increased its stake in shares of Natus Medical by 13.1% in the 2nd quarter. Daruma Capital Management LLC now owns 1,470,839 shares of the medical equipment provider’s stock valued at $54,862,000 after purchasing an additional 169,890 shares during the last quarter. Marshall Wace North America L.P. bought a new position in shares of Natus Medical in the 2nd quarter valued at $5,832,000. Finally, Dimensional Fund Advisors LP increased its stake in shares of Natus Medical by 10.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,552,938 shares of the medical equipment provider’s stock valued at $57,924,000 after purchasing an additional 151,372 shares during the last quarter. 99.94% of the stock is owned by institutional investors.

In other Natus Medical news, Director William M. Moore sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $41.01, for a total transaction of $205,050.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Dong Chune Christopher Chung sold 12,642 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $42.91, for a total value of $542,468.22. Following the completion of the transaction, the vice president now directly owns 141,414 shares of the company’s stock, valued at $6,068,074.74. The disclosure for this sale can be found here. 5.50% of the stock is currently owned by corporate insiders.

Several brokerages have recently issued reports on BABY. Zacks Investment Research lowered Natus Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday. William Blair lowered Natus Medical from an “outperform” rating to a “market perform” rating in a research report on Monday. Finally, BidaskClub lowered Natus Medical from a “hold” rating to a “sell” rating in a research report on Saturday, December 9th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. Natus Medical currently has a consensus rating of “Hold” and a consensus target price of $46.50.

Shares of Natus Medical Inc (BABY) traded up $0.40 during trading hours on Thursday, hitting $29.00. The stock had a trading volume of 1,817,134 shares, compared to its average volume of 1,242,960. The firm has a market cap of $891.01, a P/E ratio of -483.33 and a beta of 0.84. The company has a debt-to-equity ratio of 0.36, a current ratio of 4.21 and a quick ratio of 3.36. Natus Medical Inc has a 12 month low of $28.40 and a 12 month high of $43.60.

Natus Medical (NASDAQ:BABY) last announced its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.02. Natus Medical had a positive return on equity of 12.06% and a negative net margin of 0.62%. The company had revenue of $122.60 million for the quarter, compared to the consensus estimate of $122.41 million. During the same period in the previous year, the business earned $0.39 EPS. The firm’s revenue was up 34.9% compared to the same quarter last year. research analysts predict that Natus Medical Inc will post 1.74 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://stocknewstimes.com/2018/01/11/great-west-life-assurance-co-can-has-1-69-million-holdings-in-natus-medical-inc-baby.html.

About Natus Medical

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply